This trial will study why some people still have liver complications after being cured of hepatitis C. Eligible participants will have different tests and some will take medication for 12 weeks. Then they will have follow-up visits for up to 10 years.
2 Primary · 6 Secondary · Reporting Duration: 480 Weeks
Active Control
Experimental Treatment
350 Total Participants · 3 Treatment Groups
Primary Treatment: Epclusa · No Placebo Group · Phase 4
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: